Centyl med kaliumklorid

Centyl med kaliumklorid is a prescription medication used primarily to treat hypertension (high blood pressure) and edema. It is a combination product containing bendroflumethiazide, a diuretic, and potassium chloride to prevent potassium depletion.

Originally developed and marketed by Leo Pharma in Denmark, the brand was part of a major portfolio acquisition by Karo Healthcare (formerly Karo Pharma) in late 2017. Karo Healthcare is based in Sweden and specializes in consumer healthcare products and established pharmaceutical brands.

Manufacturing of such pharmaceutical products often occurs in various specialized facilities throughout Europe and the global supply chain, with Karo Healthcare managing the distribution across the Nordic region.